A disruptive technology to tackle brain cancer and glioblastoma
News
Hemerion appoints Dr Marie-Edith Bonneterre as Chief Medical Officer
Dr Marie-Edith Bonneterre has been appointed Chief Medical Officer (CMO) at Hemerion on September 19, 2023, to steer the medical and clinical strategy of our innovative therapeutic solutions. A specialist… ...
Hemerion one of 100 start-ups at Deeptech Connect
Hemerion is taking part for the first time in Deeptech Connect, an event organized by the SATTs (Tech Transfer Acceleration Companies), which brings together 100 start-ups created from disruptive technologies… ...
Hemerion welcomes Guillaume Pépy, Chairman of Initiative France
On Tuesday September 26th, Hemerion welcomed Guillaume Pépy, President of Initiative France, at the head of a delegation made up of representatives of the Initiative France network and its partners,… ...
Stay tuned to our clinical advances
They talk about us
